Hybrid peptide with functions of regulating immunity, resisting oxidation and inflammation and detoxifying body, and preparation method and application thereof

A hybrid peptide and antioxidant technology, applied in the fields of genetic engineering and biological preparations, can solve the problems of increasing the complexity and antagonism of clinical drug selection, failing to improve the immune function of the body, and reducing immunity and production performance, and achieving weight reduction. As well as intestinal damage, good immune and anti-inflammatory two-way regulation, and the effect of relieving tissue damage

Active Publication Date: 2019-08-16
CHINA AGRI UNIV
View PDF3 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are obvious problems in the use of antibiotics or hormonal anti-inflammatory drugs in the treatment of infection and inflammation: although antibiotics can reduce or kill pathogenic bacteria, they cannot improve the immune function of the body. On the contrary, the bacteria killed by antibiotics may also produce endotoxin or Exotoxins, which in turn aggravate the inflammatory response and even lead to systemic inflammatory response syndrome (Botwinski, 2001), which can cause fever, anorexia, excessive energy consumption in the body, decomposition of body tissues, and decline in immunity and production performance in animals. Avian mortality (Botwinski, 2001; Zinner, 1999)
Therefore, in the field of traditional medicine, the clear separation of anti-inflammatory drugs and immune-enhancing drugs does not meet the actual needs of the body or the interaction between anti-inflammatory and immune, and greatly increases the complexity and antagonism of clinical drug selection.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Hybrid peptide with functions of regulating immunity, resisting oxidation and inflammation and detoxifying body, and preparation method and application thereof
  • Hybrid peptide with functions of regulating immunity, resisting oxidation and inflammation and detoxifying body, and preparation method and application thereof
  • Hybrid peptide with functions of regulating immunity, resisting oxidation and inflammation and detoxifying body, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0055] Example 1 Preparation of immune anti-inflammatory hybrid peptide LTP

[0056] 1. Obtaining the hybrid peptide sequence

[0057] Through the research on the sequence, structure and the relationship between sequence structure and function of polypeptide LL-37 and thymopentin TP5, the hybridization of polypeptide LL-37 and thymopentin TP5 was carried out by protein molecular design technology, and the candidate hybrid peptide LTP was obtained , TP5-LL-37, and LL-37-TP5', the amino acid sequences of which are shown in SEQ ID NO.1, SEQ ID NO.5, and SEQ ID NO.6, respectively. Myeloid differentiation protein-2 (MD-2) binds to TLR4 and endows TLR4 with responsiveness to various ligands (including LPS); secondly, MD-2 can promote the expression of TLR4 and TLR2, and interact with TLR4 in cells distribution are closely related. Therefore, MD-2 is not only an auxiliary molecule of TLR4, but also a regulatory molecule in innate immunity, which may have a wider range of biological...

Embodiment 2

[0071] Example 2 The neutralization effect of hybrid peptide LTP on LPS

[0072] Use pyrogen-free endotoxin test water to dissolve and dilute the hybrid peptide LTP and its parent peptides LL-37 and TP5 into solutions of different concentrations (0-64 μg / mL), and take 100 μL of the above concentrations of LTP polypeptide solution and LPS respectively. (1EU / mL) mixed. After incubating at 37°C for 30 min, the neutralization rate of polypeptide LTP, LL-37, and TP5 to LPS was detected using a chromogenic mechanism Limulus kit, and polymyxin B (PMB) was used as a control. The result is as Figure 5 As shown, the polypeptide LTP has a higher LPS neutralizing activity, and its LPS neutralizing activity is equivalent to that of polymyxin B. When the concentration is 8 μg / mL, the neutralization rate of the hybrid peptide LTP to LPS is close to 100%, and Its neutralizing activity was significantly higher than that of its parent peptides LL-37 and TP5.

Embodiment 3

[0073] Example 3 Effect of Hybrid Peptide LTP on Survival Rate of Mouse Macrophage Cells

[0074] The macrophage RAW264.7 in the logarithmic growth phase was inoculated in a 96-well plate, and the initial cell culture density was 1×10 4 cells / mL, 100 μL per well, at 37°C, 5% CO 2 After culturing overnight under certain conditions, a series of LTP, LL-37, and TP5 (0-100 μg / mL) solutions were added in a series of concentration gradients. After culturing for 24 hours, the effect of polypeptide LTP on the survival rate of mouse macrophages was detected by the CCK8 method. . The result is as Figure 6 As shown, the cytotoxicity of the hybrid peptide LTP is significantly lower than that of its parent peptide LL-37, and the survival rate of macrophages is greater than 80% in the concentration range of 0-100 μg / mL, indicating that the cytotoxicity of LTP is low and has Higher security.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Login to view more

Abstract

The invention relates to a hybrid peptide with functions of regulating immunity, resisting oxidation and inflammation and detoxifying the body, and a preparation method and application thereof. The hybrid peptide named LTP is obtained through design by a protein engineering computer, heterozygosis, optimization, and in vitro and in vivo rescreening of antibacterial peptide LL-37 and thymopentin TP5, wherein the amino acid sequence is represented by SEQ ID NO.1. The hybrid peptide LTP has high bidirectional immunomodulatory activity, can enhance the immune function of the body under a normal orimmunosuppressed state, and can protect the body from injuries caused by immunosuppression; in an inflammatory state, the LTP can neutralize and eliminate endotoxin, inhibit oxidation reaction and inflammatory reaction of the body and alleviate injuries to tissues by the inflammatory reaction, has the advantages of low cytotoxicity, high safety, simplicity in preparation, low cost and the like, and can be used as an ideal immune, anti-oxidative and anti-inflammatory regulator or an immune anti-oxidative detoxification peptide, thereby having high application potential and value.

Description

technical field [0001] The invention relates to the field of genetic engineering and biological preparations, in particular to an immune, anti-oxidation and detoxification hybrid peptide with functions of immune regulation, anti-oxidation, anti-inflammation and digestion, and its preparation method and application. Background technique [0002] When animals or humans are young, weak, disease, stress, pathogenic infection, etc., their immunity is often reduced, and then secondary infection (bacterial or viral mixed infection) occurs, causing inflammatory reactions (red, hot, swollen) , pain, etc.). At present, for the treatment of infection and inflammation, the traditional and commonly used prevention and treatment strategy is to use antibiotics and hormone anti-inflammatory drugs (such as hydrocortisone, dexamethasone, etc.), although it can effectively control infectious inflammation and non-infectious inflammation, However, continuous use can cause various side effects: ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K19/00C12N15/62C12N15/81A61K38/17A61K38/32A61P39/06A61P37/02A61P29/00A61P37/04A61P31/00A61P39/02A23L33/18A23K20/147
CPCA23V2002/00A61K38/00A23K20/147A23L33/18A61P29/00A61P31/00A61P37/02A61P37/04A61P39/02A61P39/06C07K14/4723C07K14/57581C12N15/815C12N2800/22A23V2250/55A23V2200/30
Inventor 张日俊张璐璐卫旭彪黄燕阿曼斯大勇李仲玄程俊豪杜孟思
Owner CHINA AGRI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products